Norovirus is highly infectious and causing a lot of illness this winter. Several vaccine candidates are making their way through clinical trials.

The Phase 1 trial is an open label, dose ranging clinical study designed to evaluate Vaxart’s second-generation oral norovirus vaccine constructs head-to-head against its first-generation constructs.

Scientists have discovered a strategy to fight back against norovirus, a leading cause of gastroenteritis worldwide. Their new study identifies powerful antibodies capable of neutralizing a wide range ...

Infection control became a challenge among the children sheltering during the Los Angeles County fires this past January.

Scientists at The University of Texas at Austin, in collaboration with researchers from the University of North Carolina at Chapel Hill and the National Institutes of Health, have discovered a ...

Preliminary vaccine experiments typically require animal models, but researchers don’t have a good such model for norovirus. That’s because human noroviruses don’t easily infect animals ...

In an early clinical trial, an experimental norovirus vaccine given as a pill produced defensive responses exactly where it counts—in the saliva of older people most vulnerable to the explosive ...

The county health department last Friday sent letters to parents, guardians and staff members informing them that “an ...

Dr Woodnutt added: "It’s worth mentioning that while it is very rare for dogs to show human norovirus, they do experience a range of stomach bugs that are specific to them. Additionally ...

Their new study, published in Science Translational Medicine, identifies powerful antibodies capable of neutralizing a wide range of norovirus strains. The finding could lead to the design of ...

However, this is relatively rare - similar to dogs and cats getting coronavirus during the pandemic, when very few pets were infected despite hundreds of thousands of human cases." Furthermore, if ...